The role of heat shock protein 70 in regulating neuroinflammation

Yaoxue Xuebao

Volumn 50, Issue 8, 2015, Pages 945-950

  Yu, Wen Wen ^a   Bao, Xiu Qi ^a   Sun, Hua ^a   Zhang, Dan ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Heat shock protein 70; Neurodegenerative disease; Neuroinflammation; Nuclear transcription factor kappa B

Indexed keywords

HEAT SHOCK PROTEIN 70; CYTOKINE;

DEGENERATIVE DISEASE; NERVOUS SYSTEM INFLAMMATION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; BRAIN; HUMAN; INFLAMMATION; NERVE CELL; NEUROPROTECTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; UPREGULATION;

BRAIN; CYTOKINES; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTION; UP-REGULATION;

EID: 84945364277     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Ritossa F. A new puffing pattern induced by temperature shock and DNP in drosophila [J]. Cell Mol Life Sci, 1962, 18:571-573.
2. Zhu Z, Zhao X, Burkholder WF, et al. Structure analysis of substrate binding by the molecular chaperone DanK [J]. Science, 1996, 272:1606-1614.
3. Sterrenberg JN, Blatch GL, Edkins AL. Human DNAJ in cancer and stem cells [J]. Cancer Lett, 2011, 312:129-142.
4. Knapp RT, Wong MJ, Kollmannsberger LK, et al. Hsp70 cochaperones HspBPl and BAG-1M differentially regulate steroid hormone receptor function [J]. PLoS One, 2014, 9:e85415.
5. Allan RK, Ratajczak T. Versatile TPR domains accommodate different modes of target protein recognition and function [J]. Cell Stress Chaperones, 2011, 16:353-367.
6. McGeer PL, Itaqaki S, Tago H, et al. Reactive microglia with senile dementia of Alzheimer type are positive for the hisocompatibilty glycoprotein HLA-DR [J]. Neurosci Lett, 1987, 79:195-200.
7. McGeer PL, McGeer EG, Kawamata T, et al. Reaction of the immune system in chronic degenerative neurological diseases [J]. Can J Neurol Sci, 1991, 18:376-379.
8. Heneka MT, O'Banion MK, Terwel D, et al. Neuroinflammation processes in Alzheimer's disease [J]. J Neural Transm, 2010, 117:919-947.
9. Rees K, Stowe R, Patel S, et al. Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies [J]. Cochrane Database Syst Rev, 2011, 9:CD008454.
10. Gonzalez-Scarano F, Baltuch G Microglia as mediators of inflammatory and degenerative disease [J]. Annu Rev Neurosci, 1999, 22:219-240.
11. Yoo Y, Byun K, Kang T, et al. Amyloid-beta-activated human microglial cells through ER-resident proteins [J]. J Proteome Res, 2015, 14:214-223.
12. Li Y, Liu L, Barger SW, et al. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway [J]. J Neurosci, 2003, 23:1605-1611.
13. Deng X, Li M, Ai W, et al. Lipopolysaccharide-induced neuroinflammation is associated with Alzheimer's like amyloidogenic axonal pathology and dendritic degeneration in rats [J]. Adv Alzheimer Dis, 2014, 3:78-93.
14. Pisanu A, Lecca D, Mulas G, et al. Dynamic changes in proand anti-inflammation cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease [J]. Neurobiol Dis, 2014, 71:280-291.
15. Yang C, Yu L, Kong L, et al. Pyrroloquinoline quinone (PQQ) inhibits lipopolysaccharide induced inflammation in part via downregulated NF-κB and p38/JNK activation in microglial and attenuates microglia in lipopolysaccharide treatment mice [J]. PLoS One, 2014, 9:e109502.
16. Tai W, Ye X, Bao X, et al. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models [J]. Neuropharmacology, 2013, 75:201-212.
17. Njemini R, Bautmans I, Onyema OO, et al. Circulating heat shock 70 in health, aging and disease [J]. BMC Immunol, 2011, 12:24-32.
18. D'Souza SD, Antel JP, Freedman MS. Cytokine induction of heat shock protein expression in human oligodendrocytes: an interleukin-1-mediated mechanism [J]. J Neuroimmunol, 1994, 50:17-24.
19. Huang MY, Liao MH, Wang YK, et al. Effect of lavender essential oil on LPS-stimulated inflammation [J]. Am J Chin Med, 2012, 40:845-859.
20. Shim S, Kim S, Choi DS, et al. Anti-inflammatory effects of [6]-shogaol: potential of HDAC inhibition and HSP70 induction [J]. Food Chem Toxicol, 2011, 49:2734-2740.
21. Collins MA, Neafsey EJ, Wang K, et al. Moderate ethanol preconditioning of rat brain cultures engenders neuroprotection against dementia-inducing neuroinfiammatory proteins: possible signaling mechanisms [J]. Mol Neurobiol, 2010, 41:420-425
22. Doeppner TR, Kaltwasser B, Fengyan J, et al. TAT-Hsp70 induces neuroprotection against stroke via anti-inflammatory actions providing appropriate cellular microenvironment for transplantation of neural precursor cells [J]. J Cereb Blood Flow Metab, 2013, 33:1778-1788.
23. Zheng Z, Kim JY, Ma H, et al. Anti-inflammatory effects of the 70 kDa heat shock protein in experimental stroke [J]. J Cereb Blood Flow Metab, 2008, 28:53-63.
24. Hayden MS, Ghosh S. Shared principles in NF-κB signaling [J]. Cell, 2008, 132:344-362.
25. Chen G, Shi J, Hu Z, et al. Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine [J]. Mediators Inflamm, 2008, doi: 10.1155/2008/716458.
26. Chen NJ, Chio L, Lin WJ, et al. Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors [J]. Proc Natl Acad Sci USA, 2008, 105:12429-12434.
27. Feinstein DL, Galea E, Aquino DA, et al. Heat shock protein 70 suppresses astroglial-inducible nitric-oxide sythnase expression by decreasing NF-κB activation [J]. J Biol Chem, 1996, 271:17724-17732.
28. Ran R, Lu A, Zhang L, et al. Hsp70 promotes TNF-mediated apoptosis by binding IKKγ and impairing NF-κB survival signaling [J]. Genes Dev, 2004, 18:1466-1481.
29. Sheppard PW, Sun X, Khammash M, et al. Overexpression of heat shock protein 72 attenuates NF-κB activation using a combination of regulatory mechanisms in microglia [J]. PLoS Comput Biol, 2014, 10:e1003471.
30. Kizelsztein P, Komarnytsky S, Raskin I. Oral administration of triptolide ameliorates the clinical sighs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-κB/IκBα transcriptional complex [J]. J Neuroimmnuol, 2009, 217:28-37.
31. Boiocchi C, Osera C, Monti MC, et al. Are Hsp70 protein expression and genetic polymorphism implicated in multiple sclerosis inflammation? [J]. J Neuroimmunol, 2014, 268:84-88.
32. Heneka MT, Gavrilyuk V, Landreth GE, et al. Noradrenergic depletion increases inflammatory response in brain: effects on IκB and HSP70 expression [J]. J Neurochem, 2003, 85:387-398.
33. Abd-El-Fatthah MA, Abdelakader NF, Zaki HF. Pyrrolidine dithiocarbamate protects against scopolamine-induced cognitive impairment in rats [J]. Eur J Pharmacol, 2014, 723:330-338.
34. Cleren C, Callogasan NY, Chen J, et al. Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity [J]. J Neurochem, 2005, 94:995-1004.
35. Kiaei M, Kipiani K, Petri S, et al. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis [J]. Neurodegener Dis, 2005, 2:246-254.
36. Thakur P, Nehru B. Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the retenone model of Parkinson's disease [J]. Mol Neurobiol, 2015, 51:209-219.